Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)

Aims: Although intensive statin therapy reduced cardiovascular risks, cardiovascular events have not been completely prevented. Probucol is a potent antioxidant and reduces tendon xanthomas in familial hypercholesterolemia patients despite reduction of high-density lipoprotein (HDL)-cholesterol (HDL...

詳細記述

保存先:
書誌詳細
出版年:J Atheroscler Thromb
主要な著者: Yamashita, Shizuya, Arai, Hidenori, Bujo, Hideaki, Masuda, Daisaku, Ohama, Tohru, Ishibashi, Toshiyuki, Yanagi, Koji, Doi, Yasuji, Nakagawa, Satoshi, Yamashiro, Koichi, Tanabe, Kenichiro, Kita, Toru, Matsuzaki, Masunori, Saito, Yasushi, Fukushima, Masanori, Matsuzawa, Yuji
フォーマット: Artigo
言語:Inglês
出版事項: Japan Atherosclerosis Society 2021
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7957028/
https://ncbi.nlm.nih.gov/pubmed/32336695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.55327
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料